Compare KR & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KR | GEHC |
|---|---|---|
| Founded | 1883 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Computer Software: Prepackaged Software |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.9B | 27.9B |
| IPO Year | 2007 | 2022 |
| Metric | KR | GEHC |
|---|---|---|
| Price | $61.57 | $63.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $74.25 | ★ $88.38 |
| AVG Volume (30 Days) | ★ 6.2M | 2.6M |
| Earning Date | 03-05-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.09% | 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | ★ 1.46 | 0.85 |
| Revenue | ★ $147,642,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | $4.39 | $7.12 |
| Revenue Next Year | $2.30 | $4.45 |
| P/E Ratio | ★ $42.67 | $75.38 |
| Revenue Growth | 0.35 | ★ 4.84 |
| 52 Week Low | $54.15 | $58.75 |
| 52 Week High | $76.58 | $89.77 |
| Indicator | KR | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 67.57 | 29.33 |
| Support Level | $61.17 | $60.17 |
| Resistance Level | $64.44 | $65.83 |
| Average True Range (ATR) | 1.51 | 1.50 |
| MACD | 0.43 | -1.07 |
| Stochastic Oscillator | 96.44 | 7.72 |
Founded in 1883, Kroger is the largest pure-play supermarket operator in the United States, operating roughly 2,700 stores across more than 30 banners. Kroger's business is primarily grocery-led (roughly 78% of sales), spanning fresh food and private-label offerings, complemented by fuel centers (9%) and pharmacies (12%). The firm also generates income from advertising, data analytics, and manufacturing.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).